Form D · Pharmaceuticals
BTG PLC
London, X0 · CIK 0001450431
Offering snapshot reported Feb 22, 2019 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 22, 2019 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Jun 20, 2018 | Amendment | $3,851,342 | $0vs Jun 20, 2017 | 26 | SEC filing |
| Feb 23, 2018 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Jun 20, 2017 | Amendment | $3,851,342 | $0vs Jun 21, 2016 | 26 | SEC filing |
| Feb 24, 2017 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Jun 21, 2016 | Amendment | $3,851,342 | $0vs Jun 22, 2015 | 26 | SEC filing |
| Feb 26, 2016 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Dec 8, 2015 | Initial | $788,002 | No comparison | 3 | SEC filing |
| Jun 22, 2015 | Initial | $3,851,342 | No comparison | 26 | SEC filing |
| Feb 27, 2015 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Jan 15, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-232340
This filing relates to certain conditional awards of ordinary shares to employees pursuant to the Performance Share Plan.
Source: Form D, filed Feb 22, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gregory Barrett | Director |
| Susan Foden | Director |
| Sue Foden | Director |
| Graham Hetherington | Director |
| Duncan Kennedy | Director, Executive |
| Giles Kerr | Director |
| Melanie Lee | Director |
| Louise Makin | Director, Executive |
| Ian Much | Director |
| Paul Mussenden | Executive |
| Jim O'shea | Director |
| Rolf Soderstrom | Director, Executive |
| Anne Thorburn | Director |
| Garry Watts | Director |
| Richard Wohanka | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
5 Fleet Place
London, X0, EC4M 7RD
London, X0, EC4M 7RD